UNI-BOL DIN 00896454
Health Canada record
| Active ingredient(s) | TESTOSTERONE ENANTHATE 100 MG; ESTRADIOL ENANTHATE 7.5 MG; ESTRADIOL BENZOATE 1 MG |
|---|---|
| Dosage form | Liquid |
| Route | Intramuscular |
| Schedule | CONTROLLED DRUGS (CDSA IV) |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1990 |
| Current status date | 06-Jun-2023 |
| Source | Health Canada DPD |
Establishment licence of the holder
Univet Pharmaceuticals Ltd. — licence 100041, not currently licensed, last inspection rating C (2019-07-22).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TESTOSTERONE ENANTHATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02536315 | TESTOSTERONE ENANTHATE INJECTION, USP | HIKMA CANADA LIMITED | Solution | TESTOSTERONE ENANTHATE 200 MG | Marketed |
| 01936131 | ANADIOL | VETOQUINOL N A INC | Solution | TESTOSTERONE ENANTHATE 100 MG; ESTRADIOL ENANTHATE 7.5 MG; ESTRADIOL BENZOATE 1.0 MG | Cancelled Post Market |
| 00029246 | DELATESTRYL | BAUSCH HEALTH, CANADA INC. | Solution | TESTOSTERONE ENANTHATE 200 MG | Cancelled Post Market |
| 02027054 | MALOGEX LA200 LIQ 200MG/ML | GERMIPHENE CORPORATION | Liquid | TESTOSTERONE ENANTHATE 200 MG | Cancelled Post Market |
| 00147567 | NEO PAUSE INJECTION | NEOLAB INC | Solution | TESTOSTERONE ENANTHATE 100 MG; ESTRADIOL VALERATE 6.5 MG | Cancelled Post Market |
| 00739944 | PMS-TESTOSTERONE ENANTHATE INJ 200MG/ML USP | PHARMASCIENCE INC | Liquid | TESTOSTERONE ENANTHATE 200 MG | Cancelled Post Market |
| 00716936 | TESTOSTERONE ENANTHATE INJ 200MG/ML | TARO PHARMACEUTICALS INC | Liquid | TESTOSTERONE ENANTHATE 200 MG | Cancelled Post Market |
International API supply for TESTOSTERONE ENANTHATE
4 active FDA Drug Master Files.
Request a quote for UNI-BOL